3368
C. Zandanel et al. / Tetrahedron 66 (2010) 3365–3369
3. Experimental
1639, 1452, 1322, 1294, 1155, 1076; HRMS (m/z): calcd for
C
59H80O19Li: 1099.5454 [MþLi]þ; found 1099.5407; mp: 82–
3.1. General
85 ꢀC.
The general procedure for the preparation of O-glycosyl tri-
chloroacetimidates 1, 2, 3 and 4 can be found in Ref. 18a. Compound
14 was prepared accordingly to the protocol described in the Ref. 27
and compounds 18 and 21 were synthesized following reported
procedures.28 Alcohol 20 was synthesized according to Ref. 29. The
preparation of TMSNTf2 has been performed following the Ghosez’s
protocol.21
3.2.5. Synthesis of compound 11. From 100 mg of 1, 36.1 mg of 11
was recovered as a white solid (yield: 41%) (SiO2, cyclohexane/
EtOAc¼7/3, Rf¼0.60). 1H NMR (CDCl3, 400 MHz)
d (ppm):
7.27–6.81(m, 7H), 6.15–6.04 (m, 4H), 5.60–5.50 (m, 5H), 5.44–5.40
(m, 1H), 5.31 (t, J¼9.1 Hz, 1H), 5.17 (d, J¼8.0 Hz, 1H), 4.35–4.15 (m,
2H), 3.99–3.94 (m, 1H), 1.89–1.75 (m, 12H); 13C NMR (CDCl3,
100 MHz)
135.2, 135.1, 129.7, 127.3, 127.2, 126.8, 126.5, 120.7, 117.3, 99.6, 72.8,
72.5, 71.5, 69.2, 63.0,18.4; IR:
(cmꢁ1) 2959, 2929,1726,1637,1591,
d (ppm): 167.0, 166.5, 165.9, 165.8, 157.1, 135.9, 135.5,
3.2. General procedure for the glycosidation reactions of
O-glycosyl trichloroacetimidates 1, 2, 3, 4, 14, 18 and 21
promoted by TMSNTf2
n
1495, 1453, 1404, 1379, 1319, 1295, 1231, 1144, 1075, 1045, 1016;
HRMS (m/z): calcd for C28H36O1N: 546.2339 [MþNH4]þ; found
546.2338; mp: 104–106 ꢀC.
The glycosyl donor (1 equiv) was dissolved in dichloromethane
(concentration fixed at 50 mM) and alcohol 5, 10, 12 or 20
(1.2 equiv) was added. The reaction mixture was cooled down to
0 ꢀC and TMSNTf2 (0.5 equiv, freshly prepared DCM solution at
0.7 M) was slowly added. The mixture became brown after 10 min.
After stirring for 1 h at 0 ꢀC in DCM, the solvent was evaporated and
the purification is performed by column chromatography with the
indicated solvents.
3.2.6. Synthesis of compound 13. From 110.0 mg of 1, 22.0 mg of
13 was recovered as a white solid (yield: 23%) (SiO2, cyclohex-
ane/EtOAc¼7/3, Rf¼0.55). 1H NMR (CDCl3, 400 MHz)
d (ppm):
6.14–6.11 (3s, 4H), 5.60–5.51 (m, 4H), 5.42 (t, J¼9.6 Hz, 1H), 5.21
(t, J¼10.0 Hz, 1H), 5.12 (t, J¼7.6 Hz, 1H), 4.70 (d, J¼8.0 Hz, 1H),
4.37–4.20 (m, 2H), 3.88–3.82 (m, 1H), 3.62–3.59 (m, 1H), 1.94–
1.72 (m, 12H), 1.75–1.62 (m, 4H), 1.47–1.20 (m, 7H); 13C NMR-
APT (CDCl3, 100 MHz)
d (ppm): 166.6, 166.1, 165.9, 165.8,
3.2.1. Synthesis of compound 6. From 600.0 mg of 1, 411.4 mg of 6
was recovered as colourless oil (yield: 56%) (SiO2, cyclohexane/
EtOAc¼8/2, Rf¼0.46). For 1H and 13C NMR see Ref. 17b.
136.0–135.2, 127.0–126.2, 99.8, 94.6, 77.5, 76.8, 73.1, 72.1, 71.9,
71.8, 70.6, 69.6, 69.4, 67.8, 63.1, 63.0, 33.4, 31.6, 25.5, 24.0, 23.7,
18.5–18.3; IR:
n
(cmꢁ1) 2933, 2856, 1731, 1638, 1453, 1320, 1295,
1150, 1018; MM-ES (m/z): 435.1 [M-cyclohexanol]þ; mp:
3.2.2. Synthesis of compound 7. From 1.4 g of 2, 1.1 g of 7 was re-
covered as yellow oil (yield: 40%) (SiO2, cyclohexane/EtOAc¼7/3,
92–93 ꢀC.
Rf¼0.75). 1H NMR (CDCl3, 300 MHz)
d
(ppm): 7.27 (m, 5H),
3.2.7. Synthesis of compound 15. From 100 mg of 14, 32.0 mg of
15 was recovered as a white solid (yield: 37%) (SiO2, cyclohex-
6.15–5.93 (4s, 4H), 5.58–5.29 (m, 8H), 4.83 (s, 1H), 4.44 (s, 2H),
4.30–4.19 (m, 3H), 3.64 (m, 1H), 3.40 (m, 3H), 1.90–1.76 (m, 12H),
ane/EtOAc¼7/3, Rf¼0.50). 1H NMR (CDCl3, 400 MHz)
d (ppm):
1.57 (m, 4H), 1.21 (m, 16H); 13C NMR (CDCl3, 75 MHz)
d
(ppm):
5.19 (t, J¼9.6 Hz, 1H), 5.08 (t, J¼9.6 Hz, 1H), 4.98–4.93 (m, 1H),
4.58 (d, J¼8.0 Hz, 1H), 4.28–4.21 (m, 1H), 4.13–4.07 (m, 1H),
3.70–3.59 (m, 2H), 2.07 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 2.01 (s,
3H), 1.91–1.65 (m, 5H), 1.53–1.40 (m, 2H), 1.35–1.18 (m, 5H); 13C
167.0, 166.3, 166.2, 166.1, 136.2, 135.8, 135.6, 135.5, 128.4, 127.6,
126.8,126.7,126.6,126.0, 97.7, 73.0, 70.7, 70.5, 69.9, 68.8, 66.8, 62.9,
29.9–29.4, 26.3, 18.3–18.1; IR:
n
(cmꢁ1) 2927, 2854, 1728, 1638,
1454, 1321, 1294, 1135, 1081; HRMS: (m/z): calcd for C41H58O11Li:
NMR (CDCl3, 100 MHz) d (ppm): 170.9, 170.5, 169.6, 169.4, 99.5,
733.4139 [MþLi]þ; found 733.4139.
78.2, 73.1, 71.8, 68.8, 62.3, 33.3, 31.6, 25.6, 23.7, 20.9–20.7; IR:
n
(cmꢁ1) 2935, 1732, 1558, 1541, 1456, 1230,1037; HRMS (m/z):
calcd for C20H30O10Naþ: 453.1737 [MþNa]þ; found 453.1735;
mp: 80–81 ꢀC.
3.2.3. Synthesis of compound 8. From 334.4 mg of 3, 296.0 mg of 8
was recovered as colourless oil (yield: 35%) (SiO2, cyclohexane/
EtOAc¼7/3, Rf¼0.60). 1H NMR (CDCl3, 300 MHz)
d (ppm): 7.27 (m,
5H), 6.12–6.03 (m, 3H), 5.73 (t, 0.3H, J¼9.0 Hz), 5.59–5.52 (m, 3H),
5.38 (t, 0.3H, J¼7.8 Hz), 5.09–4.99 (m, 2H), 4.92 (m, 0.3H), 4.58 (d,
1H, J¼6.7 Hz); 4.51 (s, 2H), 4.23 (m, 0.7H), 3.92–3.65 (m, 1.7H),
3.51–3.38 (m, 3.8H), 1.91–1.88 (m, 9.8H), 1.69–1.51 (m, 5H), 1.26 (m,
3.2.8. Synthesis of compound 16. From 105.0 mg of 14, 24.0 mg of
16 was recovered as colourless oil (yield: 18%) (SiO2, cyclohexane/
EtOAc¼7/3, Rf¼0.32). For 1H and 13C NMR, see Ref. 17b.
17H); 13C NMR (CDCl3, 75 MHz)
d
(ppm): 166.4, 165.9, 162.3, 138.9,
3.2.9. Synthesis of compound 19. From 574.0 mg of 18, 148.0 mg of
19 was recovered as colourless oil (yield: 24%) (SiO2, cyclohexane/
135.7, 135.5, 128.5, 127.7, 127.6, 126.9, 126.5, 100.8, 96.0, 73.0, 71.7,
71.3, 70.9, 70.7, 70.0, 69.8, 69.4, 68.7, 62.0, 58.6, 30.1–29.5, 27.0–
EtOAc¼3/7, Rf¼0.3). 1H NMR (CDCl3, 300 MHz)
d (ppm): 5.32 (d,
26.0, 18.4; IR:
n
(cmꢁ1) 2927, 2854, 1729, 1639, 1453, 1322, 1293,
J¼3.0 Hz, 1H), 5.18 (t, J¼9.3 Hz, 1H), 5.07 (t, J¼7.8 Hz, 1H), 4.96–4.87
(m, 2H), 4.50 (t, J¼8.4 Hz, 3H), 4.13–4.06 (m, 6H), 3.89–3.61 (m,
14H), 3.42 (t, J¼6.0 Hz, 2H), 2.12–1.94 (m, 21H); 13C NMR-APT
1151, 1048; HRMS (m/z): calcd for C36H52O9Li: 635.3771 [MþLi]þ;
found 635.3770; mp: 82–85 ꢀC.
(CDCl3, 75 MHz)
d (ppm): 171.0–169.5, 101.5, 101.2, 76.4, 73.3,
3.2.4. Synthesis of compound 9. From 380.0 mg of 4, 100.0 mg of 9
was recovered as a white solid (yield: 23%) (SiO2, cyclohexane/
72.7, 72.2, 71.4, 71.1, 70.7–70.2, 69.5, 69.2, 67.0, 62.2, 61.1, 51.0, 21.2–
20.9; MM-ES (m/z): 855.2 [MþNH3]þ.
EtOAc¼7/3, Rf¼0.53). 1H NMR (CDCl3, 300 MHz)
d (ppm): 7.27
(m, 5H), 6.12–5.89 (6s, 7H), 5.58–5.42 (m, 7H), 5.31 (t, 1H,
J¼8.5 Hz), 5.21 (m, 1H), 5.05–4.95 (m, 2H), 4.54 (d, 1H, J¼8.5 Hz),
4.47–4.42 (m, 3H), 4.17–3.95 (m, 3H), 3.95 (m, 2H), 3.75 (m, 1H),
3.63 (m, 1H), 3.39 (m, 3H), 1.98–1.72 (m, 21H), 1.55 (m, 4H), 1.15
3.2.10. Synthesis of compound 22. From 159 mg of 21, 52.4 mg of 22
was recovered as a colourless oil (yield: 30%) (SiO2, cyclohexane/
EtOAc¼2/8, Rf¼0.3). 1H NMR (CDCl3, 300 MHz)
d (ppm): 5.21–5.06
(m, 3H), 4.94–4.87 (m, 2H), 4.57–4.48 (m, 3H), 4.40 (dd, J¼4.5 Hz,
16.2 Hz, 1H), 4.25 (t, J¼4.5 Hz, 1H), 4.15–4.13 (m, 1H), 4.03 (dd,
J¼1.8 Hz, 12.3 Hz, 1H), 3.95–3.82 (m, 2H), 3.74–3.59 (m, 14H), 3.44
(t, J¼6.0 Hz, 2H), 2.12–1.97 (m, 21H); 13C NMR-APT (CDCl3, 75 MHz)
(m, 16H),; 13C NMR-APT (CDCl3, 75 MHz)
d (ppm): 166.6–165.7,
136.0–135.1, 128.4, 127.6, 127.5, 127.2, 127.1, 126.9, 126.7, 126.2,
100.9, 100.6, 75.8, 72.8, 71.7, 71.4, 71.1, 70.6, 70.2, 69.6, 67.3, 62.3,
61.4, 29.8–29.4, 26.2, 25.8, 18.3; IR:
n
(cmꢁ1) 2929, 2856, 1750,
d (ppm): 171.2–169.5, 101.3, 101.2, 76.5, 73.4, 72.3–71.9, 70.4–70.1,